ISRCTN11752770进行中（未招募）未知
A single arm study investigating the feasibility of a clinician guided online pain management programme for people with chronic pain conditions
My Pain Ltd0 个研究点目标入组 15 人开始时间: 2015年9月16日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Over 18 years of age
- •2. Diagnosed with a chronic pain condition for at least 6 months
- •3. If medicated for anxiety or depression, on a stable dose of medication as defined by no change in medication dose for 1 month or more
- •4. Full capacity to consent
- •5. Has regular access to the Internet and a smartphone / tablet / computer
- •6. Prepared and comfortable to regularly interface with a treatment modality primarily delivered through online methods including mobile devices
- •7. Able to understand the contents and participate in the language of the programme (English only)
排除标准
- •1. People with an unstable mental health condition as determined by assessing clinician or GP
- •2. People with severe symptoms of depression >20 on Patient Health Questionnaire (PHQ-9) or suicidal/self-harming thoughts experienced more than half the days in the previous 2 weeks
- •3. People who already score highly on self-efficacy; 50 or more on the Pain Self Efficacy Scale (PSEQ; see outcomes section)
- •4. People with chronic headache, autoimmune diseases, malignant cancer pain, and facial pain
- •5. Participating in any psychological therapy for any condition at the point of recruitment
- •6. Previously accessed cognitive behavioural pain management
研究者
相似试验
尚未招募
Unknown
Technology Assisted Dietary Assessment and Advice (TADAA) Feasibility StudyCardiovascular - Coronary heart diseaseDiet and Nutrition - Other diet and nutrition disordersCardiovascular diseaseACTRN12623001084673Edith Cowan University30
未知
不适用
Imaging glioblastoma pH using CEST-MRIBrain CancerMalignant neoplasm of brainCancerISRCTN86522205niversity of Oxford19
招募中
Unknown
An open-label, single-arm study to investigate the efficacy of Favipiravir on Lassa Fever for Post Exposure Prophylaxisassa feverJPRN-jRCTs031230118Morioka Shinichiro5
进行中（未招募）
1 期
A study to understand disease biology and to test the effect and safety of inhaled nemiralisib in adult patients with APDSEUCTR2015-004876-31-GBGlaxoSmithKline Research & Development Ltd20
进行中（未招募）
1 期
Single-arm study to assess a potential effect of anti-IL-17 (Secukinumab) in the treatment of pyoderma gangrenosuPyoderma gangrenosum is an autoinflammatory disease, characterized by relapsing, painful ulcers of the skin. Treatment of PG is difficult. Patients suffer from long hospitalization, pain and reduced life quality. New therapeutic strategies are needed. Immunohistological staining show a high amount of IL-17 in PG. IL-17+ immune cells were located in proximity to cellular damage, indicating an involvement in the pathogenesis. Targeting IL-17 with neutralizing IL-17 antibodies seems promising.MedDRA version: 20.0Level: PTClassification code 10037635Term: Pyoderma gangrenosumSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2015-000762-65-DETechnische Universität München, School of Medicine, represented by Dean7